Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,471,910
-$93,621 QoQ
Shares Held
9,392
-8.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#511
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AE Wealth Management LLC holds $495,400,304 across 15 Drug Manufacturers - General names. NVS ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
563,184 | $143,031,799 | |
| 2 | ABBV |
AbbVie Inc.
|
354,989 | $89,329,385 | |
| 3 | LLY |
ELI LILLY & Co
|
64,033 | $76,803,065 | |
| 4 | AMGN |
Amgen Inc
|
177,770 | $64,374,032 | |
| 5 | PFE |
Pfizer Inc
|
1,883,141 | $45,345,994 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
542,448 | $31,255,814 | |
| 7 | MRK |
Merck & Co., Inc.
|
205,251 | $26,374,734 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
79,370 | $10,027,572 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,471,910 | 9,392 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $1,565,531 | 10,249 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,329,614 | 9,644 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $1,158,005 | 9,030 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $882,039 | 7,289 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $747,918 | 6,709 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $605,364 | 6,221 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $701,046 | 6,095 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $672,400 | 6,316 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $547,491 | 5,660 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,154,800 | 21,341 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,206,898 | 21,666 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,754,338 | 27,295 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,580,232 | 28,046 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $3,361,992 | 37,059 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $2,549,071 | 33,536 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,636,068 | 31,185 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,453,665 | 27,962 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $2,483,710 | 28,395 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,179,927 | 26,656 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,374,064 | 26,020 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $2,027,756 | 23,722 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $2,009,848 | 21,284 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,751,113 | 20,137 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,751,079 | 20,049 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,269,317 | 15,395 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||